Abstract: The present invention relates to the treatment of diseases induced by Enterobacteriae. The inventors evaluated, in a multicellular in vitro model associating cells representing human enterocytes (Caco-2 cells), goblet mucus secreting cells (HT29-MTX) and M cells, whether Bacteroides fragilis, a non-enterotoxigenic strain, could be useful to limit the severity of the Salmonella Heidelberg infection, with an hypermutator phenotype, by analyzing their impact on growth and mucosal translocation. Thus, the present invention relates to a Bacteroides fragilis strain for use in the treatment of diseases induced by Enterobacteriae in a subject in need thereof.

Abstract: The invention relates to a fibre sensor that enables the propagation of infrared light at at least one wavelength of 0.8 to 25 micrometres, the fibre successively comprising along its length a first infrared waveguide section (23), a second detection section (25) intended to come into contact with an external environment in order to detect infrared signatures interfering with the propagation of the evanescent waves propagating along the fibre (2), and a third infrared waveguide section (27). The invention is characterized in that, in the second fibre section (25) that has the detection role, the fibre (2) is constituted of a curved part, the radios of curvature of which is locally less than 2.3 millimetres.